Literature DB >> 9602657

Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies.

J W Yarnell1, C C Patterson, D Bainton, P M Sweetnam.   

Abstract

OBJECTIVE: To examine the clinical and epidemiological utility of the concepts of metabolic syndrome and insulin resistance syndrome in two prospective cohort studies of white men.
METHODS: Men aged 45-63 years were screened for evidence of ischaemic heart disease (IHD) between 1979 and 1982 and followed up at regular intervals thereafter. Non-fatal coronary events were validated from hospital records and fatal coronary events from death certificates.
RESULTS: Analysis of serum insulin concentrations in non-diabetic individuals measured at entry to the study showed no independent contribution to the prediction of subsequent IHD at 10 year follow up. Blood glucose concentrations, however, showed a small independent contribution in the combined cohort in the upper fifth of the distribution. Three different models of metabolic syndrome among non-diabetic individuals were defined based on tertiles, medians, and clusters. The predictive value of each model was assessed using logistic regression before and after adjustment for conventional and metabolic risk factors. After adjustment the odds were non-significant and close to unity.
CONCLUSIONS: This study did not detect any complex relation among the five variables defining metabolic syndrome; the excess risk seems to be no greater than can be explained by individual effects of the defining variables in a multiple logistic model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602657      PMCID: PMC1728632          DOI: 10.1136/hrt.79.3.248

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  33 in total

1.  EPIDEMIOLOGY OF THE PATERSON-KELLY SYNDROME.

Authors:  P C ELWOOD; A JACOBS; R G PITMAN; C C ENTWISTLE
Journal:  Lancet       Date:  1964-10-03       Impact factor: 79.321

2.  Screening for non-insulin-dependent diabetes mellitus: where to draw the line?

Authors:  M de Courten; P Zimmet
Journal:  Diabet Med       Date:  1997-02       Impact factor: 4.359

3.  Fasting plasma glucose as a screening test for diabetes mellitus.

Authors:  K Wiener
Journal:  Diabet Med       Date:  1997-08       Impact factor: 4.359

4.  Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland.

Authors:  K Pyöräla
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

5.  Simple measure of insulin resistance.

Authors:  J W Yarnell; C C Patterson; P M Sweetnam
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

6.  Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study.

Authors:  W Bao; S R Srinivasan; G S Berenson
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

7.  Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

Authors:  P Ducimetiere; E Eschwege; L Papoz; J L Richard; J R Claude; G Rosselin
Journal:  Diabetologia       Date:  1980-09       Impact factor: 10.122

8.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  Serum insulin and incident coronary heart disease in middle-aged British men.

Authors:  I J Perry; S G Wannamethee; P H Whincup; A G Shaper; M K Walker; K G Alberti
Journal:  Am J Epidemiol       Date:  1996-08-01       Impact factor: 4.897

10.  Myocardial ischaemia, risk factors and death from coronary heart-disease.

Authors:  G Rose; P S Hamilton; H Keen; D D Reid; P McCartney; R J Jarrett
Journal:  Lancet       Date:  1977-01-15       Impact factor: 79.321

View more
  14 in total

Review 1.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

2.  Cardiovascular Risk Factors and Ischemic Heart Disease: Is the Confluence of Risk Factors Greater Than the Parts? A Genetic Approach.

Authors:  Roberto Elosua; Carla Lluís-Ganella; Isaac Subirana; Aki Havulinna; Kristi Läll; Gavin Lucas; Sergi Sayols-Baixeras; Arto Pietilä; Maris Alver; Antonio Cabrera de León; Mariano Sentí; David Siscovick; Olle Mellander; Krista Fischer; Veikko Salomaa; Jaume Marrugat
Journal:  Circ Cardiovasc Genet       Date:  2016-04-21

Review 3.  Molecular determinants of the cardiometabolic phenotype.

Authors:  Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

Review 4.  Asthma and metabolic syndrome: Current knowledge and future perspectives.

Authors:  Laura Serafino-Agrusa; Mario Spatafora; Nicola Scichilone
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

5.  Comparison of weight in middle age, weight at 18 years, and weight change between, in predicting subsequent 14 year mortality and coronary events: Caerphilly Prospective Study.

Authors:  J W Yarnell; C C Patterson; H F Thomas; P M Sweetnam
Journal:  J Epidemiol Community Health       Date:  2000-05       Impact factor: 3.710

Review 6.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 7.  Epidemiology of the insulin resistance syndrome.

Authors:  James B Meigs
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 8.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

Review 9.  What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.

Authors:  Sean Carroll; Mike Dudfield
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

10.  Associations of cardiovascular risk factors in Al Ain, United Arab Emirates.

Authors:  Latifa M Baynouna; Anthony D Revel; Nico J D Nagelkerke; Tariq M Jaber; Aziza O Omar; Nader M Ahmed; Mohammad K Nazirudeen; Mamdouh F Al Sayed; Fuad A Nour; Sameh Abdouni
Journal:  Cardiovasc Diabetol       Date:  2009-04-16       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.